Oric Pharmaceuticals, Inc. SEC filings ORIC
Oric Pharmaceuticals, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 13, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 20, 2025 | — |
| CORRESP | Letter to the SEC | Jun 17, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2025 | — |
| D | Filing | Jun 6, 2025 | — |
| EFFECT | Filing | Feb 2, 2024 | — |
| CORRESP | Letter to the SEC | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2024 | — |
| D | Filing | Jan 30, 2024 | — |
| EFFECT | Filing | Dec 28, 2023 | — |
| CORRESP | Letter to the SEC | Dec 26, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2023 | — |
| D | Filing | Jul 5, 2023 | — |
| SC TO-I/A | Filing | Jul 21, 2022 | — |
| SC TO-I | Filing | Jun 21, 2022 | — |
| EFFECT | Filing | Apr 27, 2022 | — |
| POSASR | Filing | Mar 21, 2022 | — |
| EFFECT | Filing | Nov 12, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2020 | — |
| DRS | Filing | Jul 20, 2020 | — |
| EFFECT | Filing | Apr 23, 2020 | — |
| CERT | Filing | Apr 23, 2020 | — |
| CORRESP | Letter to the SEC | Apr 23, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2020 | — |
| CORRESP | Letter to the SEC | Apr 21, 2020 | — |
| CORRESP | Letter to the SEC | Apr 21, 2020 | — |
| 8-A12B | Filing | Apr 20, 2020 | — |
| CORRESP | Letter to the SEC | Apr 20, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2020 | — |
| CORRESP | Letter to the SEC | Mar 3, 2020 | — |
| CORRESP | Letter to the SEC | Feb 28, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2020 | — |
| DRSLTR | Filing | Jan 24, 2020 | — |
| DRS/A | Filing | Jan 24, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2020 | — |
| DRS | Filing | Dec 13, 2019 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORIC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1796280
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.